IJPRS

Home Abstract

Acute Toxicity and 28 Days Repeated Oral Toxicity Study of a Siddha Medicine Kirubagara Shanmuga Chenduram in Rats


Received On: 02/05/2014
Accepted On: 05/05/2014


Author(s)

Malathi, V., Manivasakam, M., Mohammed, M. M., Parthiban, P.


Author's Affiliation


Abstract

Siddha system of medicine is simple practical traditional, sasthric and bearing the cultural heritage of India.  Siddha medicines have significant amount of heavy metals. It was propounded that hazardous effect of heavy metals would cause toxic accumulation. Based on mode of preparation, Indian system of medicine documented safe usage of drugs since 2500 years. Kirubakara Shanmuga Chenduram (KSC), a siddha medicine contains mostly metallic ingredients. In this study we have evaluated toxicity of KSC in Wistar albino rats. The acute and 28 days repeated oral toxicity study was done according to OECD guidelines 423 and 407 respectively. In acute study, high dose 2000mg/kg/bw of drug was produced neurotoxic symptoms but there were no remarkable changes in 28 days repeated oral toxicity study. Haematological and biochemical parameters did not show any change. In quantitative analysis (ICP-OES), the heavy metals like lead, cadmium, arsenic was found in BDL and mercury was found in 0.317 ppm. In histopathology study brain, heart, lungs, kidney, liver, spleen did not show any pathology. So KSC was toxic only in high dose of 2000 mg/kg. It reveals that the therapeutic dose of KSC (202mg- thuvarai alavu) is the safe dose for clinical use for human being.


Keywords

Kirubakara Shanmuga Chenduram, Toxicity, Siddha Medicine, OECD Guideline

Cite This Article

Malathi, V., Manivasakam, M., Mohammed, M. M., & Parthiban, P. (2014). Acute Toxicity and 28 Days Repeated Oral Toxicity Study of a Siddha Medicine Kirubagara Shanmuga Chenduram in Rats. International Journal for Pharmaceutical Research Scholars (IJPRS), 3(2), 347-354.


Recent Articles

Get FREE Updates for Upcoming
Pharma News, Jobs & Conferences

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

IJPRS will use the information you provide on this form to be in touch with you and to provide updates and marketing.